



Substance abuse in parents and subsequent risk of offspring 1 
psychiatric morbidity in late adolescence and early adulthood: 2 
a longitudinal analysis of siblings and their parents 3 
ABSTRACT 4 
The effects of substance abuse on other family members are not fully established. We estimate the 5 
contribution of parental substance abuse on offspring psychiatric morbidity in late adolescence and 6 
early adulthood, with emphasis on the timing and persistency of exposure. We used a nationally 7 
representative 20% sample of Finnish families with children born in 1986-1996 (n=136,604) followed 8 
up in 1986–2011. We identified parental substance abuse and offspring psychiatric morbidity from 9 
hospital discharge records, death records and medication registers. The effects of parental substance 10 
abuse at ages 0–4, 5–9 and 10–14 on psychiatric morbidity after age 15 were estimated using 11 
population averaged and sibling fixed effects models; the latter controlling for unobserved factors 12 
shared by siblings. Parental substance abuse at ages 0-14 was associated with almost 2-fold increase 13 
in offspring psychiatric morbidity (HR=1.86, 95% CI 1.78-1.95). Adjustment for childhood parental 14 
education, income, social class and family type reduced these effects by about 50%, with some further 15 
attenuation after adjustment for time-varying offspring characteristics. In the sibling fixed effects 16 
models those exposed at 0-4 or 5-9 years had 20% (HR=1.20, 95% CI 0.90-1.60) and 33% (HR=1.33, 17 
95% CI 1.01-1.74) excess morbidity respectively. Also in sibling models those with early exposure 18 
at ages 0-4 combined with repeated exposure in later childhood had about 80-90% higher psychiatric 19 
morbidity as compared to never exposed siblings (e.g. for those exposed throughout childhood 20 
HR=1.81, 95% CI 1.01-3.25). Childhood exposure to parental substance abuse is strongly associated 21 




characteristics shared within the parental home, repeated exposure to parental substance abuse is 23 
independently associated with later psychiatric morbidity. 24 





It is well established by prior studies that excessive alcohol consumption and other substance abuse 27 
are associated with social disadvantage, poor health and higher mortality for the user [1]. However, 28 
these studies do not adequately acknowledge that substance abuse may also pose harm to others – 29 
sometimes referred to as collateral damage or spill-over effects of substance abuse [2,3]. This study 30 
assesses the impact of substance abuse on others by studying its effects on the psychiatric morbidity 31 
of a particularly vulnerable group, the children of substance users [4]. 32 
Heavy maternal drinking and other substance abuse are known to be associated with poorer birth 33 
outcomes and early life health conditions including preterm birth, low birth weight and foetal alcohol 34 
syndrome [5,1,6,7]. Prenatal exposure to alcohol and other drugs has also been shown to associate 35 
with childhood behavioural problems and cognitive development [6], and children of substance-36 
abusing mothers are more likely to be hospitalized for injuries and infectious diseases [8]. A less 37 
healthy start in life may entail consequences for offspring also in the long run. Prior evidence indicates 38 
that parental substance use disorders associate with offspring psychopathology in adolescence and 39 
early adulthood, with a particularly strong intergenerational link in alcohol and other substance use 40 
disorders [9–12]. Studies using linked population registration data from Denmark and Sweden show 41 
that parental substance use has an impact on a broad range of mental health outcomes in adolescence 42 
and early adulthood including psychiatric disorders, self-harm, and substance misuse [13,14]. 43 
However, several commentators have stressed the need for more studies using population-based 44 
family data, as most of the existing evidence is based on student, clinical, and high-risk community 45 
samples of lesser generalizability [15,12,13]. It has also been pointed out that many of the previous 46 
studies assessing health consequences of parental substance abuse still focus either on short-term 47 
effects or more general measures of lifetime exposures, and much less is known about timing or 48 





Life-course theory posits that the effect of childhood experiences on later health may depend on the 51 
timing of events [16]. During sensitive periods adverse exposures have stronger effects on later 52 
disease risk than exposures at other times. Sensitive period ‘denotes the time in which the developing 53 
child is particularly responsive to certain forms of experience or particularly hindered by their absence’ 54 
[17]. In addition to sensitive periods, life course models also stress the importance of duration and 55 
accumulation of exposures for later health outcomes. However, few studies have assessed the timing 56 
and persistency of exposure to parental substance abuse on offspring health, although cross-sectional 57 
studies have reported older children of alcoholic parents to be more resilient [15]. Two longitudinal 58 
US studies based on community samples of children of alcoholics and their controls found a strong 59 
effect of having ever experienced parental alcohol abuse, as well as time-varying effects of exposures 60 
to parental alcohol abuse on offspring externalizing behaviour [18], and maternal alcohol abuse on 61 
internalizing behaviour [19]. In a Swedish register study, parental substance abuse in childhood was 62 
consistently associated with psychiatric disorder in late adolescence and early adulthood with no 63 
evidence of particularly sensitive periods, but excess risk among those with repeated exposure [14]. 64 
Similar results were found in another Swedish study on young adult alcohol use disorders [20]. 65 
Disentangling causal pathways has also remained difficult. Families with parental substance abuse 66 
are typically also characterised by poor parental mental health and social disadvantage [13,11]. Some 67 
of the children of substance abusing parents are thus likely to face additional concurrent risk factors 68 
for poorer health outcomes. In addition to other parental health problems besides substance use, these 69 
include adverse socioeconomic characteristics, strain on family relationships, unstable home 70 
environment, disrupted parenting and child maltreatment [21,22]. Although many studies have been 71 
able to control for some of these factors, such as parental socioeconomic status, the cross-sectional 72 




mediating mechanisms. Many studies are also based on retrospective self-reports of childhood 74 
adversity. Significant residual confounding may thus bias the results. 75 
This study adds to the literature in three ways. First, we focus on the timing of exposure to parental 76 
substance abuse in three different stages of childhood (ages 0–4, 5–9 and 10–14 years) in order to 77 
establish sensitive periods of exposure. Second, we estimate the effects of repeated exposure to 78 
parental substance abuse. Third, to obtain a more accurate understanding of the mechanisms and 79 
causal effects of parental substance abuse on offspring mental health we estimate both population 80 
averaged models controlling for observed parental characteristics and time-varying offspring 81 
characteristics, as well as sibling fixed effects models that control for all unobserved characteristics 82 
shared by siblings. Finally, the analyses are based on high quality register data on a large population-83 
representative sample of Finnish families with children followed for exposures to parental substance 84 
abuse from birth to age 14, and for psychiatric morbidity from age 15 over the years 2001–2011. 85 
These administrative data are unique as they do not suffer from reporting bias, selective loss to follow-86 
up or small sample size. 87 
Data and methods 88 
Data and variables 89 
This study was based on annually updated individual-level register data maintained by Statistics 90 
Finland. We used data that consist of a 20% random sample of Finnish households with at least one 91 
child aged 0–14 at the end of 2000, a 20% sample of 0–14-year-olds not living in private households 92 
at the end of 2000, and non-coresident biological parents of all 0–14-year-olds in the two samples. 93 
The data were linked with individual-level sociodemographic information for both offspring and their 94 
parents for years 1987–2011, hospital discharge records (maintained by the National Institute for 95 
Health and Welfare) for 1986–2011, and the national prescription register on all purchases of 96 




In the current study, we included individuals born in years 1986–1996 (n=136,604) and followed 98 
them from the beginning of the year of their 15th birthday until first incidence of psychiatric morbidity, 99 
the end of the year of their 25th birthday, emigration, death, or the end of year 2011, whichever came 100 
first. Offspring psychiatric morbidity was defined on the basis of indicators available in 101 
administrative register data: psychotropic medication purchases (including the Anatomical 102 
Therapeutic Chemical (ATC) codes N05 and N06 but not N06D) or admission to inpatient hospital 103 
care with a psychiatric diagnosis (International Classification of Diseases (ICD-10) codes F10–69, 104 
F80–98) (for more detail see Supplementary Table 1). Defined in this way about 20% of all offspring 105 
psychiatric cases were based on hospital data. 106 
Exposure to parental substance abuse in each calendar year at ages 0–14 was assessed using 107 
information of hospital diagnoses and cause of death of the biological parents in years 1986–2010. 108 
We used the tenth revision of ICD for years 1996–2010 to identify mental and behavioural disorders 109 
due to alcohol (F10) and substance use (F11–16, F18–19), alcohol-related diseases (E24.4, E52, 110 
G31.2, G40.51, G62.1, G72.1, I42.6, K29.2, K70, K85.2, K86, Y90–91), toxic effects and poisoning 111 
by alcohol (T51, X45) and other substances (T40, T42.3–42.4, T42.6–42.7, T43.0–43.5, T43.8–43.9, 112 
T50.7, T36, X44) and other contact with health services due to alcohol (R78.0, Z50.2, Z71.4, Z72.0) 113 
or substance use (R78.1–78.5, Z50.3, Z71.5, Z72.2). Corresponding ICD-8 codes were used for 1986 114 
and ICD-9 codes for 1987–1995 (for more detail see Supplementary Table 1). Substance abuse was 115 
identified if any of the codes were reported as primary or additional hospital diagnosis, or as the 116 
underlying or contributory cause of death. Deaths accounted for 6% of all annual substance abuse 117 
cases. 80% of all cases were related to alcohol, of which most common were mental and behavioural 118 
disorders due to use of alcohol. We classified exposure to parental substance abuse according to the 119 





We used parental education, household income, occupational social class and family type, measured 122 
at ages 0-14, to adjust for the socioeconomic characteristics of the childhood family. Parental 123 
education at ages 0-14 was based on the highest achieved educational level of either parent in the 124 
household, and categorized as tertiary, secondary and basic education or no qualifications. The 125 
average household income across ages 0-14 was measured in terms of the household’s total income 126 
subject to state taxation, the information of which is collected by the Finnish Tax Administration and 127 
the Social Insurance Institution. To adjust for household structure, total income was divided by the 128 
number of consumption units in the household according to the modified scale of the Organisation 129 
for Economic Co-operation and Development (OECD). The scale assigns a value of 1 to the head of 130 
household, 0.5 to all other adult household members and 0.3 to all children [23]. The longest held 131 
parental occupational social class was classified as upper-white-collar, lower-white-collar, manual, 132 
farmer, self-employed, and other or unknown. The variable refers to the household’s reference person, 133 
which usually is the parent with higher income. Family type of the parental home was classified as 134 
intact two-parent family, ever single-parent family, reconstituted two-parent family and ever living 135 
with others, in institution or family type unknown (usually referring to institutional residence).  136 
Offspring social characteristics at age 15+ included family type, education and economic activity, 137 
and were measured annually as time-variant during the follow-up. Family type combined information 138 
on marital status and living arrangements, and was categorized as child, married, cohabiting, single 139 
parent, living alone, living with others and family status unknown. Education refers to both achieved 140 
qualifications and enrolment in education, classified as tertiary qualifications, secondary 141 
qualifications and enrolment in further education, secondary qualifications and not in education, basic 142 
education and enrolment in further education, basic education and not in further education. Economic 143 




We used gender, region of residence based on hospital districts (N=20), language (Finnish, Swedish, 145 
other), indicator for psychiatric morbidity before the age of 15 and calendar year as control variables 146 
in all models. 147 
Statistical methods 148 
We used Cox proportional hazards regression to estimate the relative effects of exposure to parental 149 
substance abuse at different age periods on incident psychiatric morbidity in the offspring. We 150 
estimated both standard population averaged models and sibling fixed effects models. We first 151 
estimated separate models for exposure to parental substance abuse at each 5-year period of childhood 152 
(e.g. exposed at age 0–4 vs. no exposure at this age) and exposure at any stage at ages 0–14 (ever 153 
exposed vs. never exposed). Model 1 was adjusted for gender, region of residence, language and 154 
psychiatric morbidity below age 15, and the baseline hazard was allowed to vary by calendar year 155 
(strata-option in Stata) to account for the increasing prevalence in psychotropic medication use. In 156 
the population averaged models, we further adjusted for the characteristics of the childhood family in 157 
model 2, and for time-varying offspring characteristics during the follow-up in model 3. Finally, we 158 
fitted fixed effects models based on 91,428 children in sibships. The number of siblings discordant 159 
for the outcome and exposure to parental substance abuse (ever/never; age at exposure) and thus 160 
contributing to the estimates in regression models varied between 779 and 1956 depending on the 161 
definition of exposure. These models controlled for all unobserved time-invariant characteristics 162 
shared by siblings, such as shared genetic makeup, parental resources and parenting styles. 163 
We next estimated the effects of repeated exposure during ages 0-14. Hazard ratios were calculated 164 
for the eight combinations of exposures at different age periods, the never-exposed establishing the 165 
reference group. A set of sensitivity analyses was performed to assess the robustness of these models. 166 





Main results 169 
In the first 15-years of life 6.3% of children had been exposed to parental substance abuse at least 170 
once (Table 1). The prevalence of exposure at the three age periods 0–4, 5–9 and 10–14 years was 171 
1.9, 3.0 and 3.7% respectively. Altogether about 9% of men and 15% of women experienced 172 
subsequent psychiatric morbidity between the ages 15 and 25. Among those exposed to parental 173 
substance abuse at different stages of childhood this proportion was 19–23% among men and 25–29% 174 
among women with indication of somewhat higher psychiatric morbidity if exposed early in life.  175 
These differences translate into an adjusted hazard ratio of psychiatric morbidity of about two for the 176 
exposed men and women combined (Table 2). Adjusting for social characteristics in the parental 177 
home – parental education, household income, occupational social class and family type – attenuated 178 
these associations by about half. Adjustment for offspring time-varying education, economic activity 179 
and family type during the follow-up reduced these associations further. In the sibling fixed effects 180 
model the risk of psychiatric morbidity among children ever exposed to parental substance abuse 181 
(HR=1.09; 95% CI 0.84–1.42) was not statistically different from that of the never-exposed siblings. 182 
However, our results indicate an excess risk of 20-30% for psychiatric morbidity for children exposed 183 
at ages 0–4 and 5–9 compared to siblings exposed at other ages or never. 184 
The effects of repeated exposure to parental substance abuse at different age periods were clearly 185 
amplified if children were exposed at all three age periods (Figure 1, Supplementary Table 2); those 186 
exposed throughout childhood had 2.64 (95% CI 2.29–3.04) higher risk of psychiatric morbidity in 187 
early adulthood compared to the never-exposed. For other combinations of repeated exposure at 188 
different age periods, the excess risk was typically about two-fold. In the fully adjusted models, 189 
children exposed to parental substance abuse had 20–60% higher risk of later psychiatric morbidity 190 




confirm these results by showing a high excess risk of psychiatric morbidity among children with 192 
repeated exposure to parental substance abuse as compared to never-exposed siblings.  193 
Sensitivity analyses 194 
We carried out sensitivity analyses on our main results (Supplementary Table 3). First, because 195 
biological parents do not necessarily reside with their children, parental substance abuse also does 196 
not in all cases occur while children and parents live together. To estimate the possible effects that 197 
this may have, we ignored any exposure episodes of substance abuse that occurred without co-198 
residence. Our analyses indicate that about 2/3rd of parental substance abuse took place while children 199 
were residing with biological parents. With this more restricted exposure variable the patterns of 200 
excess risk of psychiatric morbidity in early adulthood were similar to, or somewhat stronger than 201 
those observed with the broader definition of exposure. 202 
Second, our main analyses combined exposures to maternal or paternal substance abuse. Separate 203 
analyses on maternal and paternal substance abuse indicate relatively small differences, although with 204 
some tendency for maternal substance abuse having stronger effects. Third, the effects of exposure 205 
to parental alcohol abuse – 80% of all parental substance abuse exposure – were somewhat smaller 206 
than those for all substance abuse combined. 207 
Fourth, siblings were identified through the mother, and may thus have different biological fathers. 208 
Confirmatory analyses that restricted our sibling analyses to sibships that shared both biological 209 
parents showed – in concordance with our main results – that exposure early in life combined with 210 
later exposure had large effects on subsequent psychiatric morbidity, although the number of siblings 211 
were reduced in these analyses by about a 1/4th, and the confidence intervals around our estimates 212 
increased further.  213 
Finally, in order to evaluate whether our findings were sensitive to model specification, we 214 




exposure to parental substance abuse. These analyses broadly support our main analyses in indicating 216 
that early age at first exposure and repeated exposures are risk factors for later life psychiatric 217 
incidence (Supplementary Table 4).  218 
Discussion 219 
Main results and their interpretation 220 
Parental substance abuse remains a significant social problem. Based on parental medical records, 221 
over 10% of Finns born in 1991 had experienced serious parental substance abuse before age 18 [25]. 222 
Also, about one in five Finnish adults report excessive alcohol use in their childhood family [26]. 223 
Using family-based data we estimated the effects of parental substance abuse on offspring psychiatric 224 
morbidity, focusing particularly on the timing and persistency of exposure. We showed that exposure 225 
to parental substance abuse at age 0–14 was significantly associated with an almost two-fold 226 
(HR=1.86, 95% CI 1.78-1.95) increase in psychiatric morbidity in late adolescence and early 227 
adulthood. Adjustment for parental education, income, social class and family type reduced these 228 
effects by about 50%, with some further attenuation after adjustment for offspring personal time-229 
varying education, economic activity and family type. In the sibling fixed effects specification those 230 
with exposure to parental substance abuse at age 0-4 and 5–9 had 20% (HR=1.20, 95% CI 0.90-1.69) 231 
and 33% (HR=1.33, 95% CI 1.01-1.74) higher risk to experience psychiatric morbidity respectively 232 
compared to siblings not exposed at that particular age. Those with repeated exposures over the three 233 
stages of childhood had highest morbidity. In particular, in the fixed effect specification those with 234 
early exposure at ages 0-4 combined with repeated exposure had about 80-90% higher psychiatric 235 
morbidity as compared to never exposed siblings (e.g. for those exposed throughout childhood 236 
HR=1.81, 95% CI 1.01-3.25). 237 
Adjusted for demographic factors and childhood psychiatric morbidity, our estimates of the 238 




of about two – fall within the mid-range of estimates from previous studies [10,14,20,27]. Exact 240 
comparisons are difficult because study designs and measurements vary, but independent effects of 241 
parental problem drinking on offspring mental health in adulthood have also been observed in 242 
propensity score matching based analyses controlling for an extensive range of demographic, 243 
household, economic and geographic factors [28]. In our study, adjustment for observed childhood 244 
factors attenuated the effects of parental substance use by about 50%. This attenuation is more than 245 
has typically been observed in prior observational studies and we believe this is because of the lack 246 
of adjustment for family type and family change in many prior studies. However, another Finnish 247 
study showed that exposure to parental substance abuse below age seven was a significant predictor 248 
of mental disorders in adolescence and that this association was strongly attenuated after controlling 249 
for parental mental disorders, education, poverty, and family structure [27]. Overall, causal directions 250 
between parental substance abuse and other family risk factors are of course difficult to establish as 251 
it is feasible to hypothesize effects running both ways. 252 
A unique aspect of our data and study design is that we were able to estimate sibling fixed effects 253 
models. These models allow for stronger causal inference as they control for all observed family 254 
characteristics as well as characteristics shared by siblings that are not directly observed in the data. 255 
Factors that were not accounted for in the population averaged models may include stable parental 256 
characteristics related to genetic endowments, temperament or parenting styles. The effects in the 257 
fixed effects models were somewhat smaller than those in the population averaged models. However, 258 
the results from the fixed effects models demonstrate a 20–30% increase in psychiatric morbidity if 259 
exposed to parental substance abuse at ages 0–9, and thus provide more persuasive evidence for a 260 
causal effect of parental substance abuse at various stages of childhood on subsequent offspring 261 
morbidity. 262 
According to the life-course theory exposure to childhood adversities during sensitive periods may 263 




duration and accumulation of exposures may amplify effects. Overall, prior longitudinal evidence on 265 
sensitive periods to parental substance abuse is weak and inconclusive [14,18–20]. Our results 266 
provide modest evidence – both in the descriptive findings and fixed-effects models – that exposure 267 
in early childhood, particularly when combined with repeated exposure to parental substance abuse, 268 
has somewhat more harmful effects on subsequent psychiatric morbidity than exposure in later 269 
childhood. Overall, however, differences in the age at exposure appear to be relatively small. In the 270 
fixed-effect specification, those with early exposure at ages 0–4 combined with exposure also at later 271 
stages had about 80–90% higher psychiatric morbidity as compared to non-exposed siblings. 272 
Together with previous evidence on long-term and repeated exposures to parental substance use 273 
[14,19,20], these findings demonstrate significant cumulative effects. In our study we did not assess 274 
accumulation of exposures in terms of the number of substance abusing parents, but existing evidence 275 
on families with multiple members with substance use disorders also point to the importance of 276 
cumulative risk exposures in childhood [10,12,29].   277 
Methodological considerations 278 
 279 
An advantage of our data is that it allows longitudinal sibling comparisons in the association between 280 
parental substance abuse and offspring psychiatric morbidity. Specifically, the Cause-of-Death 281 
Register, the Hospital Discharge Register and the National Prescription Register used for identifying 282 
parental substance abuse and offspring psychiatric morbidity, have been shown to have good quality 283 
and practically complete national coverage [30–33]. Several Finnish studies have also shown high 284 
concordance between registered purchases and self-reported use of psychotropic medication [34–36].   285 
 286 
However, in the interpretation of our results some particularities of the data need to be considered. 287 
As both our exposure and outcome are based on registers they are likely to reflect more serious end 288 




of the exposure and outcome on the one hand and a stronger association between the two on the other. 290 
Furthermore, it is possible that the parent had been suffering from problems related to substance use 291 
already long before being admitted to the hospital. Such under-detection of pre-clinical health 292 
problems is possible with all data types. However, our analyses are unlikely to be hampered by false 293 
positive parental substance abuse cases. Thus, our identification of children exposed to parental 294 
substance use at all stages of childhood is likely to be very accurate, while identification of not 295 
exposed children an underestimate. Hence, any detection biases are likely to lead to our estimates of 296 
repeated exposure being biased downward. Ultimately, our results only provide evidence of the 297 
effects of more serious manifestations of substance abuse on offspring psychiatric morbidity.  298 
With regard to the study outcome, some misclassification may rise from non-psychiatric use of 299 
psychotropic medication for indications such as incontinence and pain [37,38], but these biases are 300 
likely to be more severe at ages older than late adolescence and early adulthood. Unfortunately, the 301 
indications of psychotropic medication prescriptions were unavailable in the data. About 20% of all 302 
offspring psychiatric cases were based on hospital data. Again, hospital-based ascertainment is likely 303 
to identify more severe cases, but additional analyses indicate that although these were more strongly 304 
affected by parental substance use than medication-based cases, the patterns were similar to our main 305 
findings. For example, being exposed to parental substance use at age 0-4 was associated with a HR 306 
of 2.45 (95% CI 2.14-2.80) for hospital-based cases and a HR of 2.03 (95% CI 1.88-2.21) for 307 
medication-based cases (results not shown). 308 
 309 
We carried out several sensitivity analyses that corroborated our findings. First, we showed that a 310 
more restricted definition of exposure that only included episodes of substance abuse that occurred 311 
with co-residence were similar to or somewhat stronger than those observed in the total sample. The 312 
tendency for stronger effects highlights the more severe nature of actually living with a parent having 313 




of the results. Our main results were also broadly replicated in models with different parameterisation 315 
of the timing and chronicity of exposure. 316 
 317 
Finally, although sibling comparison is an attractive tool to control for unmeasured confounding 318 
shared in sibships, estimates from sibling models are not without limitations. Taken together potential 319 
misclassification of concordant sibling pairs as discordant pairs, unadjusted confounders not shared 320 
by siblings or contamination effects between exposure and outcome between siblings can bias the 321 
estimates away from or towards zero. The sibling comparison estimates that we provide must thus be 322 
seen as part of a broader attempt at methodological triangulation; together with the results of our 323 
population averaged models with measured covariates as well as prior evidence based on, for example, 324 
propensity score matching techniques [28], the analyses provide reasonably strong evidence for 325 
causal effects. 326 
 327 
Conclusions 328 
Overall, we show that exposure to parental substance abuse is associated with subsequent psychiatric 329 
morbidity in offspring. In accordance with the life-course theory, repeated exposure amplified these 330 
effects, but we did not obtain strong evidence for the existence of sensitive periods of exposure. The 331 
results are based on objective measurement of exposure and outcome in health care registers that most 332 
likely reflect a more severe manifestation of problems. The analyses thus reflect the top of the iceberg, 333 
but also clearly identify the potential for intervention, as both parents and their children have been in 334 
contact with the health care system. The results highlight the need to tackle the consequences of 335 
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Figure 1 Cumulative exposure to parental substance abuse and subsequent psychiatric morbidity at the age 
of 15–25; hazard ratios (HR) from different regression models 
 
Model 1: Gender, region of residence, language, calendar year and psychiatric morbidity before the age of 
15 
Model 2: Model 1 + parental education, household income, occupational social class and family type at the 
age of 0–14 
Model 3: Model 2 + time varying family type, education and economic activity of offspring at the age of 15+ 







Table 1 Children exposed to parental substance abuse by age of exposure and subsequent psychiatric 
morbidity at the age of 15–25; number of observations (N), distribution (%) and prevalence (%) with 95 % 
confidence intervals (CI) of psychiatric morbidity 
    
Psychiatric morbidity 
    
Men Women 




9.5 (9.3—9.7) 15.1 (14.8—15.3) 




9.4 (9.2—9.7) 14.9 (14.6—15.2) 




9.4 (9.2—9.6) 15.0 (14.7—15.2) 
Yes 5035 3.7 19.2 (17.7—20.8) 25.5 (23.7—27.2) 
 
Never exposed 127979 93.7 9.2 (8.9—9.4) 14.6 (14.3—14.9) 







Table 2 Children exposed to parental substance use by age at exposure and subsequent psychiatric morbidity at the age of 15–25; hazard ratios (HR) and 
95 % confidence intervals (CI) from different regression models 
    
Model 1 Model 2 Model 3 
Sibling fixed-
effectsᵃ      
Age Exposure N % HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
0-4 No 133993  1.00  1.00  1.00  1.00  
Yes 2611 1.9 2.04 (1.88-2.20) 1.44 (1.33-1.56) 1.36 (1.25-1.47) 1.20 (0.90-1.60)  
 
 
         
5-9 No 132462  1.00  1.00  1.00  1.00  
Yes 4142 2.9 1.99 (1.87-2.12) 1.45 (1.36-1.55) 1.37 (1.28-1.46) 1.33 (1.01-1.74)  
 
 
         
10-14 No 131569  1.00  1.00  1.00  1.00  
Yes 5035 3.4 1.79 (1.69-1.90) 1.33 (1.25-1.41) 1.25 (1.18-1.34) 0.97 (0.77-1.23) 
Total never 127979 93.7 1.00  1.00  1.00  1.00  
Total ever 8625 6.3 1.86 (1.78-1.95) 1.40 (1.33-1.47) 1.33 (1.26-1.40) 1.09 (0.84-1.42) 
Model 1: Gender, region of residence, language, calendar year and psychiatric morbidity before the age of 15 
Model 2: Model 1 + parental education, household income, occupational social class and family type at the age of 0-14  
Model 3: Model 2 + time-varying family type, education and economic activity of offspring at the age of 15+ 






Supplementary Table 1 The Anatomical Therapeutic Chemical (ATC) and the International Classification of 
Diseases 9th (ICD-9 for 1987–1995ᵃ) and 10th (ICD-10 for post-1996) Revision codes for identifying offspring 
psychiatric morbidity and parental substance abuse 
Offspring psychiatric morbidity ATC ICD-10 
 Psycholeptics N05 
 
 
Psychoanaleptics (excl. anti-dementia 
drugs) 
N06 (excl. N06D) 
 
 
Mental and behavioural disorders (excl. 




   




Mental and behavioural disorders due to 
use of alcohol 
291, 303, 3050 F10 
 Alcoholic polyneuropathy 3575 G62.1 
 Alcoholic cardiomyopathy 4255 I42.6 
 Alcoholic gastritis 5353 K29.2 
 Alcoholic liver disease 5710–5713 K70 
 
Alcohol-induced pancreatitis 5770D–5770F, 5771C–
5771D 
K85.2, K86.0 
 Toxic effects of alcohol 980 T51 
 Accidental poisoning by alcohol E851 X45 
 
Other alcohol-related diseases 2650A, 5307A E24.4, E52, G31.2, G40.51, 
G72.1, Y90–91 
 
Contact with health services due to use of 
alcohol 
 
R78.0, Z50.2, Z71.4, Z72.1 
Other substances   
 
Mental and behavioural disorders due to 
psychoactive substance use (excl. alcohol 
and tobacco) 




Poisoning 965, 967, 9685, 9690–
9699, 9701 
T40, T42.3–42.4, T42.6–42.7, 
T43.0–43.5, T43.8–43.9, 
T50.7, T36ᵇ, X44ᵇ 
 




 Other diseases related to substance use   B17.1, B18.2 
  
Contact with health services due to 
substance use 
  R78.1–78.5, Z50.3, Z71.5, 
Z72.2 
ᵃ Corresponding ICD-8 codes were used for 1986 
ᵇ From 1998 onwards, ICD-10 codes F55, T36 and X44 have been used together with ATC codes to indicate 
the poisoning-causing substance (N02A, opioids; N02B/N05A/N06, non-dependence-producing substances; 





Supplementary Table 2 Cumulative exposure to parental substance use and subsequent psychiatric morbidity at the age of 15–25; hazard ratios (HR) and 
95 % confidence intervals (CI) from different regression models 
 
Age at exposure 
   
0-4 No Yes  
 
5-9   No   Yes   No   Yes 
 
 
10-14 No Yes No Yes No Yes No Yes 
  
 HR  HR  HR  HR  HR  HR  HR  HR  
  
  (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Total N 
           
 
Cox regression  
 
Model 1 1.00 1.60 1.82 2.05 1.93 1.70 2.14 2.64  
 
  (1.48-1.74) (1.65-2.01) (1.83-2.31) (1.72-2.17) (1.31-2.21) (1.80-2.55) (2.29-3.04)  
 
Model 2 1.00 1.27 1.41 1.49 1.48 1.15 1.51 1.74  
 
  (1.16-1.38) (1.27-1.55) (1.32-1.67) (1.31-1.66) (0.88-1.49) (1.27-1.80) (1.51-2.02)  
 
Model 3 1.00 1.22 1.35 1.37 1.41 1.06 1.39 1.60  
 
  (1.12-1.32) (1.22-1.50) (1.21-1.54) (1.25-1.58) (0.81-1.38) (1.17-1.66) (1.38-1.85)              
N 127979 2985 1867 1162 1219 279 504 609 136604 
            
 
Sibling fixed-effects  
 
Model 1 1.00 0.98 1.21 1.30 1.08 1.03 1.99 1.81  
 
  (0.73-1.33) (0.81-1.82) (0.85-2.00) (0.69-1.70) (0.51-2.08) (1.07-3.68) (1.01-3.25)  
            
Nᵃ 86518 1826 1087 667 654 131 241 304 91428 
 
Model 1: Gender, region of residence, language, calendar year and psychiatric morbidity before the age of 15 
Model 2: Model 1 + parental education, household income, occupational social class and family type at the age of 0-14  










Supplementary Table 3 Cumulative exposure to parental substance abuse and subsequent psychiatric morbidity at the age of 15–25; hazard ratios (HR) and 
95 % confidence intervals (CI) from different regression models 
 Age at exposure  
0-4 No Yes  
5-9   No   Yes   No   Yes  
10-14 No Yes No Yes No Yes No Yes  
 HR  HR  HR  HR  HR  HR  HR  HR   
  (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Total N 
          
 Cox regression 
 
Only coresident parent's 
substance abuseᵃ 
1.00 1.27 1.40 1.41 1.36 0.84 1.26 1.93  
 (1.14-1.42) (1.25-1.56) (1.13-1.75) (1.22-1.52) (0.49-1.41) (1.00-1.59) (1.42-2.64)  
N 131229 1670 1477 343 1386 87 287 125 136604 
Only father's substance 
abuseᵃ 
1.00 1.10 1.26 1.37 1.33 1.16 1.24 1.56   
  (1.00-1.22) (1.12-1.42) (1.20-1.58) (1.17-1.52) (0.86-1.58) (1.01-1.53) (1.32-1.85)   
N 130198 2154 1374 852 1016 194 392 424 136604 
Only mother's substance 
abuseᵃ 
1.00 1.33 1.47 1.34 1.41 1.02 1.96 1.55  
 (1.17-1.51) (1.26-1.71) (1.09-1.65) (1.15-1.72) (0.62-1.66) (1.47-2.60) (1.15-2.10)  
N 133868 1056 654 321 361 75 134 135 136604 
Only parental alcohol 
abuseᵃ 
1.00 1.19 1.27 1.25 1.24 1.16 1.30 1.40   
  (1.09-1.31) (1.13-1.42) (1.09-1.43) (1.08-1.42) (0.87-1.56) (1.07-1.59) (1.17-1.68)   
N 129715 2483 1489 931 968 211 398 409 136604 
           
Sibling fixed effects  
Fixed effects: shared 
biological mother and 
fatherᵇ 
1.00 0.89 1.26 1.13 0.95 0.82 1.96 1.48  
 (0.62-1.29) (0.73-2.17) (0.63-2.03) (0.52-1.72) (0.31-2.21) (0.88-4.39) (0.65-3.40)  
Nᶜ 83318 1696 947 592 551 97 202 243 87646 
ᵃ Model 3; see Model 3 terms in Supplementary Table 2; ᵇ Model 1; see Model 1 terms in Supplementary Table 2; ᶜ Number of children in sibships out of 








Supplementary Table 4 Age at first exposure to parental substance abuse and subsequent psychiatric 
morbidity at the age of 15–25; hazard ratios (HR) and 95 % confidence intervals (CI), children ever exposed 
to parental substance abuse at the age of 0–14 (n=8,625) 
 One Two Three Four or more 
  HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI 
Age at first exposure        
0-4 1.00  0.77 (0.61-0.98) 0.97 (0.75-1.25) 1.14 (0.95-1.37) 
5-9 0.95 (0.80-1.12) 0.99 (0.80-1.22) 0.95 (0.75-1.21) 1.00 (0.80-1.23) 
10-14 0.86 (0.74-1.01) 0.80 (0.63-1.02) 0.91 (0.65-1.28) 0.86 (0.45-1.62) 
N 4845   1593   836   1351   
Model 3; see Model 3 terms in Supplementary Table 2     
 
 
 
